首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 核酸藥物

市場調查報告書

商品編碼

1390695

2023-2028年按類型、製造商類型、合成技術、給藥途徑、應用和地區分類的胜肽治療市場報告

Peptide Therapeutics Market Report by Type, Type of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2023-2028

出版日期: 2023年11月24日 | 出版商:

IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

2022年全球胜肽治療市場規模達392億美元。展望未來， IMARC Group預計到2028年市場規模將達到661億美元，2022-2028年複合年成長率（CAGR）為9.10%。

胜肽是有效的選擇性訊號分子，可與特定的細胞表面受體（例如離子通道和 G 蛋白偶聯受體 (GPCR)）結合並觸發細胞內效應。他們在製藥業設計新型再生療法，可以針對多種細胞並操縱它們的反應。與其他治療方案相比，這些療法毒性較小、相對安全且耐受性良好。因此，它們在世界各地治療癌症、損傷、傳染病、代謝紊亂和美學問題的臨床實踐中越來越受歡迎。

胜肽治療市場趨勢：

急性和慢性疾病的日益流行，以及醫療設施的普及，是積極影響胜肽開發創新療法需求的主要因素之一。此外，胜肽療法也用於藥妝手術，以減緩皮膚老化的過程。再加上人們對外表的意識不斷增強以及對保持年輕健康皮膚的渴望，正在推動整容手術和胜肽療法在世界各地的採用。除此之外，隨著減少注射頻率、提高穩定性和其他物理特性的新型合成策略的引入，肽療法被廣泛用於糖尿病患者的注射。這與糖尿病發病率的增加以及對快速和精確治療方法的日益偏好相結合，正在影響肽療法相對於口服藥物的使用。此外，個人化和標靶治療的新興趨勢正在催化對多功能胜肽基材料的需求。再加上開發用於治療自體免疫和發炎性疾病的新型胜肽療法的資金不斷增加，預計將創造積極的市場前景。

本報告回答的關鍵問題

全球肽治療市場有多大？
2023-2028年全球胜肽治療市場的預期成長率是多少？
推動全球胜肽治療市場的關鍵因素是什麼？
COVID-19 對全球胜肽治療市場有何影響？
全球肽治療市場按類型分類是怎樣的？
根據製造商類型，全球胜肽治療市場的詳細情形如何？
基於合成技術的全球胜肽治療市場的詳細情形如何？
根據給藥途徑，全球胜肽治療市場的詳細情形如何？
基於應用的全球胜肽治療市場的詳細情形如何？
全球胜肽治療市場的關鍵區域有哪些？
誰是全球胜肽治療市場的主要參與者/公司？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 12 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 15 章：價格分析

第16章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Amgen Inc.
- Apitope International NV
- Arch Biopartners Inc.
- AstraZeneca plc
- Circle Pharma Inc.
- Corden Pharma GmbH
- F. Hoffmann-La Roche AG
- Ipsen Group
- Lonza Group AG
- Novo Nordisk A/S
- Pfizer Inc.
- Teva Pharmaceuticals Industries Ltd.
- Zealand Pharma A/S

簡介目錄圖表

Product Code: SR112023A4510

Abstract

The global peptide therapeutics market size reached US$ 39.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 66.1 Billion by 2028, exhibiting a growth rate (CAGR) of 9.10% during 2022-2028.

Peptides are efficacious and selective signaling molecules that bind to specific cell surface receptors, such as ion channels and G protein-coupled receptors (GPCRs) and trigger intracellular effects. They are employed in the pharmaceutical industry to design novel regenerative therapeutics that can target a wide range of cells and manipulate their responses. These therapeutics are less toxic, relatively safe, and well-tolerated than other treatment options. As a result, they are gaining traction in clinical practices worldwide to manage cancer, injuries, infectious diseases, metabolic disorders, and aesthetic concerns.

Peptide Therapeutics Market Trends:

The growing prevalence of acute and chronic diseases, along with the rising access to medical facilities, represents one of the leading factors positively influencing the demand for peptides to develop innovative therapies. Moreover, peptides therapies are used in cosmeceutical surgeries to slow down the process of skin aging. This, coupled with the increasing consciousness among individuals about physical appearance and the desire to retain young and healthy skin, is driving the adoption of cosmetic surgeries and peptide therapeutics around the world. Apart from this, with the introduction of novel synthetic strategies that reduce injection frequency and improve stability and other physical properties, peptide therapeutics are widely being used in injections for diabetic patients. This, in confluence with the increasing incidence of diabetes and the growing preference for quick and precise treatment methods, is influencing the use of peptide therapeutics over oral medications. Furthermore, the emerging trend of personalized and targeted treatments is catalyzing the demand for multifunctional peptide-based materials. This, along with the rising funding to develop novel peptide therapeutics for treating autoimmune and inflammatory diseases, is projected to create a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global peptide therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, type of manufacturer, synthesis technology, routes of administration and application.

Breakup by Type:

Innovative

Generic

Breakup by Type of Manufacturer:

Outsourced

In-house

Breakup by Synthesis Technology:

Solid Phase Peptide Synthesis

Liquid Phase Peptide Synthesis

Hybrid Technology

Breakup by Routes of Administration:

Parenteral

Oral

Others

Breakup by Application:

Gastrointestinal Disorders

Neurological Disorders

Metabolic Disorders

Cancer

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Apitope International NV, Arch Biopartners Inc., AstraZeneca plc, Circle Pharma Inc., Corden Pharma GmbH, F. Hoffmann-La Roche AG, Ipsen Group, Lonza Group AG, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceuticals Industries Ltd. and Zealand Pharma A/S.

Key Questions Answered in This Report

1. How big is the global peptide therapeutics market?
2. What is the expected growth rate of the global peptide therapeutics market during 2023-2028?
3. What are the key factors driving the global peptide therapeutics market?
4. What has been the impact of COVID-19 on the global peptide therapeutics market?
5. What is the breakup of the global peptide therapeutics market based on the type?
6. What is the breakup of the global peptide therapeutics market based on the type of manufacturer?
7. What is the breakup of the global peptide therapeutics market based on the synthesis technology?
8. What is the breakup of the global peptide therapeutics market based on the routes of administration?
9. What is the breakup of the global peptide therapeutics market based on the application?
10. What are the key regions in the global peptide therapeutics market?
11. Who are the key players/companies in the global peptide therapeutics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Peptide Therapeutics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Innovative
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Generic
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Type of Manufacturer

7.1 Outsourced
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 In-house
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Synthesis Technology

8.1 Solid Phase Peptide Synthesis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Liquid Phase Peptide Synthesis
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Hybrid Technology
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Routes of Administration

9.1 Parenteral
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Oral
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Application

10.1 Gastrointestinal Disorders
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Neurological Disorders
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Metabolic Disorders
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
10.4 Cancer
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
10.5 Others
- 10.5.1 Market Trends
- 10.5.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia-Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 Amgen Inc.
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
  - 16.3.1.3 Financials
  - 16.3.1.4 SWOT Analysis
- 16.3.2 Apitope International NV
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
- 16.3.3 Arch Biopartners Inc.
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
  - 16.3.3.3 Financials
- 16.3.4 AstraZeneca plc
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
  - 16.3.4.3 Financials
  - 16.3.4.4 SWOT Analysis
- 16.3.5 Circle Pharma Inc.
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
- 16.3.6 Corden Pharma GmbH
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
- 16.3.7 F. Hoffmann-La Roche AG
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
  - 16.3.7.3 SWOT Analysis
- 16.3.8 Ipsen Group
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
  - 16.3.8.3 Financials
  - 16.3.8.4 SWOT Analysis
- 16.3.9 Lonza Group AG
  - 16.3.9.1 Company Overview
  - 16.3.9.2 Product Portfolio
  - 16.3.9.3 Financials
  - 16.3.9.4 SWOT Analysis
- 16.3.10 Novo Nordisk A/S
  - 16.3.10.1 Company Overview
  - 16.3.10.2 Product Portfolio
  - 16.3.10.3 Financials
  - 16.3.10.4 SWOT Analysis
- 16.3.11 Pfizer Inc.
  - 16.3.11.1 Company Overview
  - 16.3.11.2 Product Portfolio
  - 16.3.11.3 Financials
  - 16.3.11.4 SWOT Analysis
- 16.3.12 Teva Pharmaceuticals Industries Ltd.
  - 16.3.12.1 Company Overview
  - 16.3.12.2 Product Portfolio
  - 16.3.12.3 Financials
  - 16.3.12.4 SWOT Analysis
- 16.3.13 Zealand Pharma A/S
  - 16.3.13.1 Company Overview
  - 16.3.13.2 Product Portfolio
  - 16.3.13.3 Financials

簡介目錄圖表

List of Figures

Figure 1: Global: Peptide Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Peptide Therapeutics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Peptide Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Peptide Therapeutics Market: Breakup by Type (in %), 2022
Figure 5: Global: Peptide Therapeutics Market: Breakup by Type of Manufacturer (in %), 2022
Figure 6: Global: Peptide Therapeutics Market: Breakup by Synthesis Technology (in %), 2022
Figure 7: Global: Peptide Therapeutics Market: Breakup by Routes of Administration (in %), 2022
Figure 8: Global: Peptide Therapeutics Market: Breakup by Application (in %), 2022
Figure 9: Global: Peptide Therapeutics Market: Breakup by Region (in %), 2022
Figure 10: Global: Peptide Therapeutics (Innovative) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Peptide Therapeutics (Innovative) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Peptide Therapeutics (Generic) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Peptide Therapeutics (Generic) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Peptide Therapeutics (Outsourced) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Peptide Therapeutics (Outsourced) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Peptide Therapeutics (In-house) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Peptide Therapeutics (In-house) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Peptide Therapeutics (Hybrid Technology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Peptide Therapeutics (Hybrid Technology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Peptide Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Peptide Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Peptide Therapeutics (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Peptide Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Peptide Therapeutics (Other Routes of Administration) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Peptide Therapeutics (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Peptide Therapeutics (Neurological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Peptide Therapeutics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Peptide Therapeutics (Metabolic Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Peptide Therapeutics (Metabolic Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Peptide Therapeutics (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Peptide Therapeutics (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Peptide Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Peptide Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: North America: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: North America: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: United States: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: United States: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Canada: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Canada: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Asia-Pacific: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Asia-Pacific: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: China: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: China: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Japan: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Japan: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: India: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: India: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: South Korea: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: South Korea: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Australia: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Australia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Indonesia: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Indonesia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Europe: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Europe: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Germany: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Germany: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: France: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: France: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: United Kingdom: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: United Kingdom: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Italy: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Italy: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Spain: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Spain: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Russia: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Russia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Latin America: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Latin America: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Brazil: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Brazil: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Mexico: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Mexico: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Middle East and Africa: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Middle East and Africa: Peptide Therapeutics Market: Breakup by Country (in %), 2022
Figure 88: Middle East and Africa: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Global: Peptide Therapeutics Industry: SWOT Analysis
Figure 90: Global: Peptide Therapeutics Industry: Value Chain Analysis
Figure 91: Global: Peptide Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Peptide Therapeutics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Peptide Therapeutics Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Peptide Therapeutics Market Forecast: Breakup by Type of Manufacturer (in Million US$), 2023-2028
Table 4: Global: Peptide Therapeutics Market Forecast: Breakup by Synthesis Technology (in Million US$), 2023-2028
Table 5: Global: Peptide Therapeutics Market Forecast: Breakup by Routes of Administration (in Million US$), 2023-2028
Table 6: Global: Peptide Therapeutics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 7: Global: Peptide Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Peptide Therapeutics Market: Competitive Structure
Table 9: Global: Peptide Therapeutics Market: Key Players

02-2729-4219

+886-2-2729-4219